Cargando…

BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions

Several bacterial pathogens have TIR domain-containing proteins that contribute to their pathogenesis. We identified a second TIR-containing protein in Brucella spp. that we have designated BtpB. We show it is a potent inhibitor of TLR signaling, probably via MyD88. BtpB is a novel Brucella effector...

Descripción completa

Detalles Bibliográficos
Autores principales: Salcedo, Suzana P., Marchesini, María I., Degos, Clara, Terwagne, Matthieu, Von Bargen, Kristine, Lepidi, Hubert, Herrmann, Claudia K., Santos Lacerda, Thais L., Imbert, Paul R. C., Pierre, Philippe, Alexopoulou, Lena, Letesson, Jean-Jacques, Comerci, Diego J., Gorvel, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703528/
https://www.ncbi.nlm.nih.gov/pubmed/23847770
http://dx.doi.org/10.3389/fcimb.2013.00028
Descripción
Sumario:Several bacterial pathogens have TIR domain-containing proteins that contribute to their pathogenesis. We identified a second TIR-containing protein in Brucella spp. that we have designated BtpB. We show it is a potent inhibitor of TLR signaling, probably via MyD88. BtpB is a novel Brucella effector that is translocated into host cells and interferes with activation of dendritic cells. In vivo mouse studies revealed that BtpB is contributing to virulence and control of local inflammatory responses with relevance in the establishment of chronic brucellosis. Together, our results show that BtpB is a novel Brucella effector that plays a major role in the modulation of host innate immune response during infection.